Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications
Abstract Background Our understanding of the pathophysiology of the COVID-19 manifestations and evolution has improved over the past 10 months, but the reasons why evolution is more severe in obese and diabetic patients are not yet completely understood. Main text In the present review we discuss th...
Main Authors: | Andrey Santos, Daniéla Oliveira Magro, Rosana Evangelista-Poderoso, Mario José Abdalla Saad |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13098-021-00639-2 |
Similar Items
-
Efficacy and safety of evogliptin versus sitagliptin as add on to metformin alone in a combined russian-korean population. Evo-combi trial
by: Alina Y. Babenko, et al.
Published: (2018-10-01) -
Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
by: Wondmkun YT
Published: (2020-10-01) -
Identification of Multiple Pancreatic and Extra-Pancreatic Pathways Underlying the Glucose-Lowering Actions of <i>Acacia arabica</i> Bark in Type-2 Diabetes and Isolation of Active Phytoconstituents
by: Prawej Ansari, et al.
Published: (2021-06-01) -
Evaluation of the Antidiabetic and Insulin Releasing Effects of <i>A. squamosa</i>, Including Isolation and Characterization of Active Phytochemicals
by: Prawej Ansari, et al.
Published: (2020-10-01) -
Dysregulation of DPP4 Is Associated with the AMPK/JAK2/STAT3 Pathway in Adipocytes Under Insulin Resistance Status and Liraglutide Intervention
by: Cheng F, et al.
Published: (2019-12-01)